Solubility issues

The stoichiometric oxidative coupling of various phenols proceeds with moderate selectivity (76% ee) in the presence of (-)-sparteine CuCl2, Eq. 106 (127). As mentioned above, selectivity seems to be driven by solubility issues since isolation of the product from the precipitate or from solution results in different enantiose-lectivities. Indeed, this system performs far worse under catalytic conditions. The best result involves the use of silver chloride as reoxidant the heterooxidative coupling of two naphthols 182 and 183 affords the product 184 in 41% yield and 32% ee using 10 mol% catalyst, Eq. 107. 

The final development of the enzyme product after identification of the inhibitor and establishment of an industrial production process turned out relatively easy after initial solubility issues were solved. 

Water is a unique solvent because of its high polarity and ability to form a network of H-bonds. It is immiscible with many organic solvents and is therefore a suitable solvent for use in biphasic reactions in which catalysts are made preferentially soluble in the aqueous phase. Phase transfer catalysis allows the use of aqueous reagents with substrates that have low solubility in water. That water is abundant and totally non-toxic make it the perfect clean solvent, provided that solubility issues can be overcome, and it is in use as a solvent on an industrial scale for polymerization, hydroformylation, and a range of organic chemistry involving PTC. These applications are discussed further in Chapters 7-11. 

The sample must be soluble If it s not in solution, it cannot be analyzed by HPLC. Although this may seem obvious, solubility issues complicate real assays of low-solubility drugs and controlled-release formulations. Many situations encountered in pharmaceutical analysis, such as low recovery, lack of mass balance, and out-of-specification results, might stem from solubility problems in a sample preparation step, rather than the HPLC analysis itself. 

Low concentrations of organic solvent (<1%, v/v preferably <0.1%) should be used to dissolve substrates and NCEs which may lead to compound solubility issues. Higher percentages of organic solvents in the final reaction volume can inhibit enzyme activity [23-25]. No inhibitor control samples, reflecting 100% activity, should be solvent-matched with the test incubations. 

The third compound was CNS-active (target H). The feasible dose levels in animals were limited to five or six times the anticipated human dose due to convulsions associated with mortality. In FETAX (Table 4), the majority of malformed larvae were noted at the top dose of the standard range (1-62.5 mg/L) and included microencephaly and eye defects. As with the two other false positive compounds, no solubility issues were noted. Interestingly at the dose of 62.5 mg/L, all larvae appeared anesthetized, remaining stationary and not reacting to touch, probably in relation with its pharmacological activity. 

The solubility and homogeneity of the sample are key to accurate analysis. This solubility can be affected by other ingredients in the product to be analyzed. Certain situations may require use of a much smaller sample size to account for solubility issues. Proper steps must be taken to grind or homogenize the sample to... 

In 1980 Karampurala et al prepared V02+, Mn2+, Zn2+, Cr3+, and Fe3+-based Schiff base polymers from 5,5 -methylene bis-salicylaldehyde and aniline.4 Similar to the polymers prepared by O Connell, all of these polymers are insoluble in common organic solvents. It is not possible to characterize these insoluble polymers by conventional methods, such as osmometry and visco-metry, and only elemental analyses and IR can be used for characterization. Instead of 5,5 -methylene bis-salicylaldehyde, hydrazinecarboxamide was subsequently used as monomer for the reactions (Fig. 14).30 However, the solubility issue had not been resolved, all of the V02+, Mn2+, Zn2+, Cr3+, and Fe3+ Schiff base polymers are insoluble in common solvents. 

B. Early Work Focused on Solubility Issues and Fermentation. 438... 

On entering the stomach an oral dose must first dissolve in the aqueous environment, prior to being absorbed across the walls of the gastrointestinal tract. The rate and extent of dissolution is therefore an important parameter. Solubility issues are discussed elsewhere in this book (see Chapter 4), but it is important to note that any new drug must possess the correct balance between aqueous solubility, allowing it to dissolve in the stomach and lipophilicity, to permit transfer across biological membranes. Poor solubility can result in a low oral bioavailability, although this problem may be resolved in some instances by judicious choice of formulation. 

Helgeson, H. C., The Robert M. Garrels Memorial Issue, Geochim. Cosmochim. Acta 56, No. 8 (August 1992). A marvelous collection of research papers on mineral solubility issues, dedicated to one of the giants of aqueous geochemistry. 

For the safety pharmacological evaluation this method allows the administration of necessary high doses by i.d. or i.p. administration probably as suspension (methylcellulose) irrespective of solubility issues of the candidate compound. 

Determining target concentration is important because it must work for most processes after the sample is solubilized to a certain concentration. After solubilization, a lower concentration solution may be achieved by dilution, but it is no longer possible to fill a request for a higher concentration. Therefore, a compound management laboratory must ensure the concentration is high enough to cover the needs of its customers. Further, more solubility issues may arise as the concentration increases. 

The main drawback in the use of water (low solubility of most organic substances in water) would be overcome by using surfactants, which solubilize organic materials or form emulsions with them in water. To address this solubility issue, therefore, we planned to use surfactants, hopefully small amounts of them, for the Lewis acid-catalysed reactions in water. 

In this chapter, we present results of the testing of a broad spectrum of polymers in carbon dioxide over a range of temperatures and pressures and evaluation of the effect of the high pressure carbon dioxide on the chemical/physical properties of materials tested. The testing was performed in a static manner with four controlled variables, namely temperature, pressure, treatment time and decompression time. The evaluation of the interaction of high pressure carbon dioxide with polymers included sorption and swelling behavior, solubility issue, plasticization and crystallization, and mechanical properties. The results of these evaluations are discussed in three sections Sorption, Swelling and Dissolution of Carbon Dioxide in Polymers at Elevated Pressure, Thermal Properties, and Mechanical Properties. ... 

The sorption of carbon dioxide can result in swelling and/or dissolution of a polymer. The extent of either/or both swelling and dissolution depends on the solubility of carbon dioxide in the polymer and/or the solubility of the polymers in carbon dioxide. When the system pressure is reduced, absorbed carbon dioxide may nucleate into bubbles and cause the formation of foam, or small defects in the polymer structure that may significantly alter the mechanical properties of the material. In addition, carbon dioxide can extract the plasticizer, if present, in the polymer and thus cause embrittlement. In this chapter, we address such solubility issues. 

---